Morgan Stanley Reiterates Overweight on iRhythm Technologies, Maintains $149 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Cecilia Furlong has reiterated an Overweight rating on iRhythm Technologies (NASDAQ:IRTC), maintaining a price target of $149.
July 11, 2023 | 1:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has reiterated an Overweight rating on iRhythm Technologies, maintaining a price target of $149.
The Overweight rating from Morgan Stanley indicates a positive outlook for iRhythm Technologies. The maintained price target of $149 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100